Sanjay Subramanian - Oct 15, 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Chief Financial Officer
Signature: /s/ Sanjay Subramanian
Stock symbol: OCGN
Transactions as of: Oct 15, 2021
Transactions value $: -$62,082
Form type: 4
Date filed: 10/15/2021, 04:01 PM
Previous filing: Aug 18, 2021
Next filing: Oct 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Options Exercise	$17.5K	+7.99K	+17.53%	$2.19	53.6K	Oct 15, 2021	Direct
transaction	OCGN	Common Stock	Sale	-$79.6K	-7.99K	-14.91%	$9.96	45.6K	Oct 15, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Option (Right to Buy)	Options Exercise	$0	-7.99K	-50%	$0.00	7.99K	Oct 15, 2021	Common Stock	7.99K	$2.19	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.96 to $9.97. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3	The option, initially representing a right to purchase a total of 23,970 shares, vests and becomes exercisable in equal annual installments over a three year period commencing on October 1, 2020, subject to continued employment with the Company on the applicable vesting dates.